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HEALTHCAREREFORM
The Role of Government in Health Care Reform
in the United States and England
In the past, stark differences between the pluralistic,
market-drivenhealthsystemintheUnitedStatesandthe
single-payer, centrally managed system in the United
Kingdomhaveresulted in richopportunities for those in-
terested in comparative health system analysis. These
differences are real but look like they are becoming less
marked as a consequence of recent trends toward di-
rectgovernmental intervention in theUnitedStatesand
the use of market forces in the English National Health
Service (NHS). In this respect, England contrastsmark-
edly with the devolved nations of Scotland,Wales, and
Northern Ireland,whichtoagreateror lesserextenthave
rejected a role for competition in their health services.
The apparent convergence of health policies in the
UnitedStatesandEngland isprincipallydrivenbyaprag-
matic desire to address the challengeof increasing value
by improving health care quality while at the same time
controlling medical costs. The challenge is common to
both countries, but its antecedents differ. In England,
policy makers have regarded inertia, a lack of patient-
centeredness inhowcare isdelivered,andstrongprofes-
sional vested interests as their main challenges. There-
fore, theyperceivecompetitionasa reasonablesolution.
In the United States, policy makers view a lack of plan-
ning,unacceptable inequalities inthecarereceivedbypa-
tients, high costs, and strong corporate vested interests
as theirmainchallenges.Consequently, theyseegovern-
mental interventionas theanswer. Inbothcountries, the
relationship between government and the health sys-
tem is changing inways that are likely to be far reaching.
Perhaps a convergence between public and pri-
vate does not require the United States or England to
change their health systemsasmuchas ispopularlyper-
ceived.Mostphysiciangroupsandhospitals intheUnited
Statesareprivatelyowned.However, publicprograms—
primarily Medicare, Medicaid, and the Department of
Veterans Affairs health system—provide coverage to
more than one-third of the population.1
If thehealthsystemintheUnitedStates isnotwholly
privatized, then it is equally misleading to characterize
England as having a purely public systemof health care
delivery. Since its inception, theNHSaccepteda role for
a private sector, allowing most non–hospital-based cli-
nicians to work as independent contractors to a cen-
trallymanagedservice. In2011, approximately 13%ofall
elective (nonemergency) surgical procedures among
residentsof theUnitedKingdomwereprivately funded.2
In the early 1990s, a sharp focus on competition was
introduced into the NHS with the establishment of an
“internal market,” which separated the role of the NHS
as a payer for health care services from its role as a
provider of these services. Formost of the last decade,
there has been a consensus across the political parties
in England in favor of the use of the private sector in
health care. Thepolitical argumenthasbeenabouthow
much. More recent policy initiatives continue to ac-
tively encourage market forces, in particular the 2012
HealthandSocialCareAct,whichestablisheda legalbasis
for competition between organizations that provide
publicly funded health services.3
Governmentshaveacentral role indetermining the
public-privatebalanceof their health systems.Theycan
attempt to exert an influence in several different ways.
First, theycandeterminehowmuchofthecostsofhealth
care isbudgeted fromthepublicpurse.ThePatientCare
andAffordable Care Act (hereafter the Affordable Care
Act) in the United States has increased public funding
marginallybut less thancriticsclaim.TheAffordableCare
Act has expanded public and private coverage and, de-
pending on the number of states that eventually opt to
expand their Medicaid programs, is expected to in-
crease the percentage of Americans with public cover-
agebya fewadditionalpercentagepoints.4Despitepoli-
cies promoting the private sector, in the English NHS
between1997and2011, thepercentageofprivatehealth
expenditure shrank from 19.6% to 17.2%.5 Overall, the
government in both countries seems reluctant or un-
able to use its role as payer as amajor lever for change.
Second, governments can influence the balance
between public and private ownership of physician
groups, hospitals, andother entities thatprovidehealth
care. In theUnitedStates, there is little interest in chang-
ing theoverwhelminglyprivateownershipofhealthcare
provision. In England, there have been a few instances
in which private organizations have secured contracts
tooperatepublic hospitals andprimary care clinics, and
some of these experiments have resulted in high-
profile failures.6 Again, the government in both coun-
tries seems to have little interest in exercising much
influence in this area.
Third,governmentscanalter theways inwhichphy-
sicians and hospitals are organized. It is ironic that, in
both countries, this role is the area in which govern-
mentshave the least authorityandyetareexercising the
greatest influence. In theUnited States, the Affordable
Care Act has contributed to major organizational
changes, with the consolidation of organizations that
provide health care and amuch stronger focus on inte-
gration between medical groups and hospitals. Simi-
larly, in England, a combination of national policies and
economicpressureshas led toan increase inmergersof
both hospitals and general practices and the emer-
VIEWPOINT
MartinMarshall,MD
Department of Primary
Care and Population
Health, University
College London,
London, England.
AndrewB.Bindman,
MD
Department of
Medicine, University
of California,
San Francisco; and
Department of
Epidemiology &
Biostatistics, University
of California,
San Francisco.
Author Audio
Interview at
jamainternalmedicine
.com
Corresponding
Author:Martin
Marshall, MD,
Department of Primary
Care and Population
Health, University
College London,
Sir Ludwig Guttman
Centre, 40 Liberty
Bridge Rd, East Village,
Olympic Park,
Stratford, London
E20 1AS, England
(martin.marshall
@ucl.ac.uk).
Opinion
jamainternalmedicine.com (Reprinted) JAMA Internal Medicine January 2016 Volume 176, Number 1 9
Downloaded From:  by a University College London User  on 10/31/2017
Copyright 2016 American Medical Association. All rights reserved.
gence of new integratedmodels of care (eg, where acute care hos-
pitalsassumeresponsibility formanagingprimaryorcommunityser-
vices). In summary, despite different policy approaches, the
United States andEngland seemheaded toward similar health care
landscapes characterized by some competition among a limited
number of integrated providers.
Irrespective of their market or governmental orientation,
policy makers in both countries are reconsidering the relationships
among payers, physicians, hospitals, and primary care clinics in
their pursuit of higher-value care. In England, the emphasis on
increasing value has, at least until recently, been more on quality
than on cost. For example, the Quality and Outcomes Framework,
established in 2004, tied a large portion of payment to primary
care physicians to their performance on a range of quality indica-
tors. This framework has had a substantial effect on the way that
general practice is organized and delivered.7 In the United States,
the emphasis on value has focused more on lowering costs. The
Affordable Care Act directs the Medicare program to pursue alter-
native payment models, such as shared savings for physicians and
hospitals participating in Accountable Care Organizations who
meet quality standards and are able to lower costs. Medicare has
set a goal of having 50% of its beneficiaries receiving care from
physicians and hospitals who are reimbursed through alternative
payment models that hold them accountable for quality and cost
by 2018.8
In the United States and England, these new payment
approaches have had mixed success,7,9 suggesting that to achieve
the goal of higher-value care policy makers will need to take addi-
tional steps beyond aligning the financial incentives among pay-
ers, physicians, and organizations that provide health services. In
particular, policy makers will need to actively promote the compo-
nents of their health system that enable change, including better
integrated data systems, a workforce that has the capacity and
capability to work effectively, and organizations that value a spirit
of inquiry and a commitment to continuous learning. Govern-
ments should also help payers, physicians, and hospitals to priori-
tize their key challenges. They should ensure that the focus of
resources is in the right place, namely, away from the provision of
acute care and toward the provision of preventive care and
primary care.10
Faced with similar challenges and goals, as well as uncertainty
about thebestpolicy solutions, theUnitedStates andEnglandhave
much to learn from each other in reforming health care. For
example, the United States needs help in establishing policies that
will encourage a primary care workforce that is as well developed
and geographically distributed as the workforce in England. En-
glandalsohasmuchto learn fromtheexperience in theUnitedStates
ofdeliveringpopulation-basedcaremanagement throughAccount-
able Care Organizations. Ultimately, success in both countries will
depend on, first, an unremitting focus on promoting collaboration
among payers, physicians, organizations that provide health ser-
vices, and the people who use health services and, second, a con-
sistentcommitmentofpolicymakers tosupport rigorous, timely,and
independent evaluations of health care policies.
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